Harvard Apparatus Regenerative Technology Inc. published an update to their financial calendar
Harvard Bioscience, Inc. HBIO | 5.20 | +2.16% |
Biostage, Inc. HRGN | 1.68 | 0.00% |
Harvard Bioscience, Inc. will release its fourth quarter 2025 financial results before the market opens on March 12, 2026, with the earnings release and related slide presentation available in the Investor Relations section of its website. The company will also host an earnings conference call on March 12, 2026 at 8:00 a.m. ET; participants who want to join the call and ask a question must register via here, and audio-only webcast access is available via here.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harvard Apparatus Regenerative Technology Inc. published the original content used to generate this news brief on February 26, 2026, and is solely responsible for the information contained therein.
